AEON Biopharma, Inc.

NASDAQ (USD): AEON Biopharma, Inc. (AEON)

Last Price

0.174

Today's Change

+0.065 (59.09%)

Day's Change

0.108 - 0.223

Trading Volume

589,792,760

Overview

Market Cap

13 Million

Shares Outstanding

79 Million

Avg Volume

3,728,616

Avg Price (50 Days)

0.59

Avg Price (200 Days)

1.70

PE Ratio

-8.67

EPS

-0.02

Earnings Announcement

11-Nov-2024

Previous Close

0.11

Open

0.11

Day's Range

0.1077 - 0.2226

Year Range

0.101 - 17.17

Trading Volume

590,930,976

Price Change Highlight

1 Day Change

58.03%

5 Day Change

-12.21%

1 Month Change

-73.35%

3 Month Change

-84.25%

6 Month Change

-93.94%

Ytd Change

-68.50%

1 Year Change

-97.51%

3 Year Change

-98.12%

5 Year Change

-98.12%

10 Year Change

-98.12%

Max Change

-98.12%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment